Czech Republic avoids security order in plasma saga

The Commercial Court in London has refused to order the Czech Republic to pay security for the award or security for costs while it challenges a US$650 million investment treaty award over a blood plasma business – calling the investors’ costs estimate “absurdly high”.

Unlock unlimited access to all Global Arbitration Review content